Release Date: 31/01/12 13:48 Summary: December Quarter Activities Report Price Sensitive: Yes Download Document 1.07MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%